Category Archives: Food & Drug Recalls

FDA prohibits Ranbaxy’s Toansa, India facility from producing and distributing drugs for the U.S. market

The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug products. The Toansa facility is now subject to certain terms of a consent decree of permanent injunction entered against Ranbaxy in January 2012.

Lochiel Enterprises Limited Recalls St Mary’s River Smokehouses Oven Smoked Salmon Stix, Chili Mango Flavor Because of Possible Health Risk

Lochiel Enterprises Limited of Sherbrooke, NS is voluntarily recalling 56 lbs of ST MARY’S RIVER SMOKEHOUSES OVEN SMOKED ATLANTIC SALMON STIX, CHILI MANGO FLAVOR, because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and still births among pregnant women.

FDA Deputy Commissioner for Foods and Veterinary Medicine Michael R. Taylor’s Statement on the Institute of Medicine Report on Caffeine in Food and Dietary Supplements

The FDA thanks the Institute of Medicine (IOM) for convening the Aug. 5-6, 2013, public workshop on caffeine in food and dietary supplements. The FDA requested the workshop because we know how important it is to get the science right. The summary report that IOM issued today will be extremely informative as we continue our investigation of the safety of caffeine, particularly its effects on children and adolescents.